Neuropharmacology of venlafaxine (Q34093686)

31 July 2017

1 reference

title

Neuropharmacology of venlafaxine (English)

1 reference

31 July 2017

1 reference

Roseboom PH

1

1 reference

31 July 2017

Kalin NH

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2000

1 reference

31 July 2017

published in

Depression and Anxiety

1 reference

31 July 2017

volume

12 Suppl 1

1 reference

31 July 2017

page(s)

20-29

1 reference

Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

A new technique for recording compliance of human hand veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Clomipramine enhances prolactin and growth hormone responses to L-tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The role of corticotropin-releasing factor in depression and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The effect of chronic antidepressant administration on beta-adrenoceptor function of the rat pineal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Binding of antidepressants to human brain receptors: focus on newer generation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Pharmacology of Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Melatonin synthesis: adenosine 3',5'-monophosphate and norepinephrine stimulate N-acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Pharmacological modulation of human cardiac Na+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The role of corticotropin releasing factor in depressive illness: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Venlafaxine exhibits pre-clinical antidepressant activity in the resident-intruder social interaction paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Acute and chronic antidepressant drug treatments induce opposite effects in the social behaviour of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Opposite effects of acute and repeated administration of desmethylimipramine on adrenergic responsiveness in rat pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Two fatal cases of venlafaxine poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

The analgesic effect of tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1520-6394%282000%2912%3A1%2B%3C20%3A%3AAID-DA3%3E3.0.CO%3B2-M

10.1002/1520-6394(2000)12:1+<20::AID-DA3>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

release_xnbvwvrg5nad5a3ksofo7uidcu

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xnbvwvrg5nad5a3ksofo7uidcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference